Fabienne Brilot-Turville’s research
At least 5% of all
people with multiple sclerosis experience the clinical onset of their disease
prior to 18 years.
Brilot-Turville’s research at The Children’s Hospital Westmead and University
of Sydney will identify the earliest immune responses against the brain in
children who develop MS. Identifying
these early immune responses will allow early and directed treatments to
prevent disability and death in the future.
events that cause MS in all sufferers are determined in childhood. Paediatric patients are important as they
offer the opportunity to investigate the earliest possible inflammatory
reaction against the brain before progression to MS and therefore, to
understand MS causation.